Status:
COMPLETED
Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation
Lead Sponsor:
Yonsei University
Collaborating Sponsors:
Astellas Pharma Korea, Inc.
Conditions:
Liver Transplant Rejection
Eligibility:
All Genders
20-70 years
Brief Summary
Liver is an organ that is well-known for its immune tolerant capacity. However, there were still controversial issues about the impact of immunologic challenge after liver transplantation on the graft...
Detailed Description
Study Design: Target study population is forty patients who will undergo liver transplantation for 1 year in YUHS. Pediatric and early mortality cases will be excluded. Blood sample will be collected ...
Eligibility Criteria
Inclusion
- Liver recipients who undergo liver transplantation between Mar, 2011 and Feb, 2012
- Patients who can be followed for more than 3 months after transplantation
Exclusion
- Age under 20 years
- Multi-organ transplantation
- Not agree with informed consent
- Patient who had plant to be transferred to other country or center
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01444079
Start Date
April 1 2011
End Date
February 1 2014
Last Update
January 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, Seoul, South Korea, 120-752